Biotechnology
The Biotechnology industry has a total of 599 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.29 billion.
Market Cap
1.11T
Revenue
105.29B
Profits
-41.66B
PE Ratio
n/a
Profit Margin
-39.57%
Dividend Yield
0.04%
599 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 119.17B | -2.99% | 2,115,159 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 82.18B | -1.39% | 1,049,239 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 52.77B | -5.47% | 1,400,599 | 3.21B |
| 4 | ARGX | argenx SE | 49.71B | -3.33% | 377,460 | 3.68B |
| 5 | INSM | Insmed Incorporated | 36.31B | -3.26% | 2,647,108 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 35.45B | -4.04% | 419,227 | 4.97B |
| 7 | BNTX | BioNTech SE | 23.77B | -1.23% | 677,499 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 23.24B | -2.73% | 3,057,453 | 2.35B |
| 9 | INCY | Incyte Corporation | 20.79B | -4.21% | 2,304,753 | 4.81B |
| 10 | RVMD | Revolution Medicines, Inc. | 20.76B | 4.56% | 13,605,815 | - |
| 11 | GMAB | Genmab A/S | 20.66B | -0.80% | 970,076 | 3.85B |
| 12 | ROIV | Roivant Sciences Ltd. | 15.15B | -0.91% | 6,902,055 | 20.33M |
| 13 | SMMT | Summit Therapeutics Inc. | 14.52B | -0.95% | 1,891,752 | - |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.23B | -0.61% | 1,754,952 | 353.78M |
| 15 | MRNA | Moderna, Inc. | 13.23B | -5.66% | 9,217,561 | 2.23B |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.21B | -1.96% | 2,048,514 | 966.96M |
| 17 | ASND | Ascendis Pharma A/S | 12.81B | -2.12% | 442,252 | 758.59M |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.63B | -0.88% | 269,535 | 740.64M |
| 19 | EXEL | Exelixis, Inc. | 11.89B | -4.42% | 2,728,374 | 2.29B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 11.59B | -1.57% | 2,147,957 | 3.09B |
| 21 | RNA | Avidity Biosciences, Inc. | 10.90B | - | 2,268,947 | 20.87M |
| 22 | TECH | Bio-Techne Corporation | 10.06B | -0.72% | 1,955,060 | 1.22B |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 9.74B | -5.38% | 2,336,172 | 4.16B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.00B | -8.69% | 3,850,189 | 6.23M |
| 25 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.83B | -1.05% | 6,965,214 | 829.45M |
| 26 | HALO | Halozyme Therapeutics, Inc. | 8.48B | -3.97% | 2,867,551 | 1.24B |
| 27 | AXSM | Axsome Therapeutics, Inc. | 8.45B | -1.84% | 748,617 | 561.26M |
| 28 | NUVL | Nuvalent, Inc. | 7.97B | -3.89% | 520,139 | - |
| 29 | CAI | Caris Life Sciences, Inc. | 7.97B | -1.84% | 3,392,677 | 649.06M |
| 30 | CYTK | Cytokinetics, Incorporated | 7.74B | -3.21% | 1,497,245 | 87.21M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 7.36B | 0.60% | 786,032 | 7.46M |
| 32 | KRYS | Krystal Biotech, Inc. | 7.22B | 1.03% | 437,059 | 373.16M |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.50B | -4.07% | 593,464 | 174.33M |
| 34 | PTCT | PTC Therapeutics, Inc. | 6.17B | -0.50% | 1,624,259 | 1.78B |
| 35 | BLTE | Belite Bio, Inc | 6.15B | -0.12% | 478,307 | - |
| 36 | KYMR | Kymera Therapeutics, Inc. | 6.00B | -2.23% | 744,197 | 43.74M |
| 37 | PCVX | Vaxcyte, Inc. | 5.93B | -1.61% | 987,214 | - |
| 38 | COGT | Cogent Biosciences, Inc. | 5.41B | -1.93% | 1,929,410 | - |
| 39 | CRSP | CRISPR Therapeutics AG | 5.37B | -2.74% | 1,511,544 | 38.34M |
| 40 | IMVT | Immunovant, Inc. | 5.33B | -1.57% | 1,380,275 | - |
| 41 | APGE | Apogee Therapeutics, Inc. | 5.23B | -1.86% | 1,316,561 | - |
| 42 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.05B | -0.19% | 2,334,249 | 1.54M |
| 43 | PTGX | Protagonist Therapeutics, Inc. | 5.01B | -2.60% | 1,487,246 | 209.22M |
| 44 | CELC | Celcuity Inc. | 4.84B | -4.12% | 874,189 | - |
| 45 | GPCR | Structure Therapeutics Inc. | 4.63B | 1.10% | 776,004 | - |
| 46 | ACAD | ACADIA Pharmaceuticals Inc. | 4.55B | -1.86% | 1,303,155 | 1.05B |
| 47 | TGTX | TG Therapeutics, Inc. | 4.46B | 0.53% | 2,313,159 | 531.90M |
| 48 | FOLD | Amicus Therapeutics, Inc. | 4.42B | -0.14% | 17,696,818 | 598.70M |
| 49 | ADMA | ADMA Biologics, Inc. | 4.30B | -3.99% | 2,332,199 | 488.56M |
| 50 | LEGN | Legend Biotech Corporation | 4.25B | 1.36% | 2,587,513 | 909.05M |
| 51 | SRRK | Scholar Rock Holding Corporation | 4.25B | -5.79% | 1,197,417 | - |
| 52 | MIRM | Mirum Pharmaceuticals, Inc. | 4.22B | -0.46% | 758,598 | 471.79M |
| 53 | TERN | Terns Pharmaceuticals, Inc. | 4.11B | -5.57% | 2,741,977 | - |
| 54 | NAMS | NewAmsterdam Pharma Company N.V. | 4.06B | 0.99% | 711,529 | 35.24M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 3.94B | 0.05% | 117,927 | 251.23M |
| 56 | CORT | Corcept Therapeutics Incorporated | 3.84B | -1.27% | 1,863,713 | 741.17M |
| 57 | ACLX | Arcellx, Inc. | 3.72B | -1.08% | 1,210,762 | 35.90M |
| 58 | ARQT | Arcutis Biotherapeutics, Inc. | 3.66B | 1.01% | 1,695,893 | 317.93M |
| 59 | VKTX | Viking Therapeutics, Inc. | 3.58B | -2.25% | 3,037,292 | - |
| 60 | VERA | Vera Therapeutics, Inc. | 3.39B | -2.03% | 1,048,865 | - |
| 61 | CGON | CG Oncology, Inc. | 3.38B | -1.22% | 1,274,260 | 2.17M |
| 62 | APLS | Apellis Pharmaceuticals, Inc. | 3.32B | -0.87% | 3,203,128 | 1.02B |
| 63 | TARS | Tarsus Pharmaceuticals, Inc. | 3.32B | 0.17% | 422,005 | 366.10M |
| 64 | CNTA | Centessa Pharmaceuticals plc | 3.22B | -2.82% | 1,230,746 | 15.00M |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.19B | -3.78% | 865,834 | 214.83M |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.19B | -2.14% | 1,014,196 | 7.50M |
| 67 | TVTX | Travere Therapeutics, Inc. | 3.19B | -1.87% | 1,558,525 | 435.83M |
| 68 | DYN | Dyne Therapeutics, Inc. | 3.01B | -5.83% | 1,692,295 | - |
| 69 | IRON | Disc Medicine, Inc. | 2.99B | -2.04% | 262,870 | - |
| 70 | NUVB | Nuvation Bio Inc. | 2.90B | -4.41% | 4,262,959 | 26.75M |
| 71 | VRDN | Viridian Therapeutics, Inc. | 2.89B | -0.79% | 1,842,654 | 70.79M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.78B | -0.53% | 1,361,392 | 578.20M |
| 73 | BEAM | Beam Therapeutics Inc. | 2.76B | -3.21% | 1,943,299 | 55.70M |
| 74 | LQDA | Liquidia Corporation | 2.76B | 2.48% | 1,104,468 | 69.22M |
| 75 | WVE | Wave Life Sciences Ltd. | 2.71B | -3.89% | 3,152,085 | 109.23M |
| 76 | DNLI | Denali Therapeutics Inc. | 2.67B | 0.71% | 1,757,427 | - |
| 77 | EWTX | Edgewise Therapeutics, Inc. | 2.64B | 1.22% | 707,736 | - |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.64B | -7.97% | 1,623,518 | 240.00M |
| 79 | MLYS | Mineralys Therapeutics, Inc. | 2.62B | -6.28% | 1,558,550 | - |
| 80 | AAPG | Ascentage Pharma Group International | 2.56B | -1.17% | 3,175 | 54.52M |
| 81 | TLX | Telix Pharmaceuticals Limited | 2.55B | 1.73% | 86,634 | 664.23M |
| 82 | MESO | Mesoblast Limited | 2.53B | 3.17% | 284,631 | 17.20M |
| 83 | RXRX | Recursion Pharmaceuticals, Inc. | 2.45B | -3.29% | 17,181,317 | 43.69M |
| 84 | SLNO | Soleno Therapeutics, Inc. | 2.44B | 2.50% | 2,884,817 | 98.68M |
| 85 | ADPT | Adaptive Biotechnologies Corporation | 2.44B | -4.60% | 2,074,384 | 252.75M |
| 86 | SRPT | Sarepta Therapeutics, Inc. | 2.43B | -1.32% | 3,085,374 | 2.41B |
| 87 | OCUL | Ocular Therapeutix, Inc. | 2.42B | -1.04% | 2,710,277 | 55.78M |
| 88 | SYRE | Spyre Therapeutics, Inc. | 2.34B | -2.93% | 569,282 | - |
| 89 | IMNM | Immunome, Inc. | 2.26B | 2.35% | 3,160,912 | 9.68M |
| 90 | RARE | Ultragenyx Pharmaceutical Inc. | 2.24B | -4.09% | 2,681,888 | 630.60M |
| 91 | IBRX | ImmunityBio, Inc. | 2.21B | 1.82% | 7,680,885 | 82.56M |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 2.18B | 0.85% | 439,352 | 825.94M |
| 93 | GLPG | Galapagos NV | 2.17B | -0.15% | 102,583 | 336.64M |
| 94 | VCEL | Vericel Corporation | 2.06B | 0.94% | 669,360 | 258.72M |
| 95 | ZLAB | Zai Lab Limited | 2.06B | -2.79% | 1,463,376 | 441.63M |
| 96 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | -4.31% | 1,171,021 | 265.81M |
| 97 | OLMA | Olema Pharmaceuticals, Inc. | 2.01B | -5.54% | 1,306,707 | - |
| 98 | STOK | Stoke Therapeutics, Inc. | 1.92B | -4.24% | 630,023 | 205.63M |
| 99 | ALMS | Alumis Inc. | 1.90B | 1.45% | 9,889,956 | 22.12M |
| 100 | NRIX | Nurix Therapeutics, Inc. | 1.89B | 0.76% | 1,360,502 | 83.69M |
| 101 | MAZE | Maze Therapeutics, Inc. | 1.87B | -3.52% | 145,344 | 2.50M |
| 102 | SNDX | Syndax Pharmaceuticals, Inc. | 1.86B | -3.26% | 1,570,341 | 111.30M |
| 103 | MNKD | MannKind Corporation | 1.85B | 2.74% | 7,469,754 | 313.79M |
| 104 | CLDX | Celldex Therapeutics, Inc. | 1.82B | -1.48% | 777,454 | 2.60M |
| 105 | ZYME | Zymeworks Inc. | 1.73B | -7.04% | 1,322,080 | 134.48M |
| 106 | ARDX | Ardelyx, Inc. | 1.70B | 20.07% | 15,585,830 | 398.23M |
| 107 | IMCR | Immunocore Holdings plc | 1.67B | -2.10% | 344,096 | 379.59M |
| 108 | KOD | Kodiak Sciences Inc. | 1.65B | -1.66% | 797,289 | - |
| 109 | ERAS | Erasca, Inc. | 1.65B | 12.38% | 19,186,329 | - |
| 110 | GLUE | Monte Rosa Therapeutics, Inc. | 1.65B | 8.72% | 3,525,977 | 181.54M |
| 111 | AGIO | Agios Pharmaceuticals, Inc. | 1.64B | -1.33% | 1,095,479 | 44.79M |
| 112 | DNTH | Dianthus Therapeutics, Inc. | 1.63B | 0.08% | 514,527 | 3.08M |
| 113 | SION | Sionna Therapeutics, Inc. | 1.63B | -15.30% | 391,816 | - |
| 114 | PGEN | Precigen, Inc. | 1.63B | -4.95% | 3,857,221 | 6.31M |
| 115 | PHVS | Pharvaris N.V. | 1.62B | -0.16% | 232,498 | - |
| 116 | TYRA | Tyra Biosciences, Inc. | 1.62B | 0.73% | 749,539 | - |
| 117 | FTRE | Fortrea Holdings Inc. | 1.61B | -0.29% | 1,191,745 | 2.76B |
| 118 | BHVN | Biohaven Ltd. | 1.51B | -3.24% | 2,790,820 | - |
| 119 | TNGX | Tango Therapeutics, Inc. | 1.49B | -6.23% | 4,800,040 | 66.50M |
| 120 | UPB | Upstream Bio, Inc. | 1.49B | -1.92% | 502,731 | 2.80M |
| 121 | INVA | Innoviva, Inc. | 1.47B | 0.56% | 624,832 | 388.52M |
| 122 | MNMD | Mind Medicine (MindMed) Inc. | 1.45B | 4.78% | 3,522,087 | - |
| 123 | QURE | uniQure N.V. | 1.44B | 0.30% | 1,617,841 | 15.75M |
| 124 | ATAI | AtaiBeckley Inc. | 1.44B | -0.75% | 3,361,264 | 3.02M |
| 125 | TRVI | Trevi Therapeutics, Inc. | 1.44B | -4.27% | 1,298,886 | - |
| 126 | EYPT | EyePoint, Inc. | 1.41B | -1.67% | 737,492 | 42.34M |
| 127 | TSHA | Taysha Gene Therapies, Inc. | 1.41B | -3.20% | 2,544,893 | 6.31M |
| 128 | SVRA | Savara Inc. | 1.39B | -0.17% | 1,112,085 | - |
| 129 | RLAY | Relay Therapeutics, Inc. | 1.39B | -2.20% | 3,355,613 | 8.36M |
| 130 | ELVN | Enliven Therapeutics, Inc. | 1.38B | 50.29% | 9,486,857 | - |
| 131 | MBX | MBX Biosciences, Inc. | 1.38B | -5.62% | 424,672 | - |
| 132 | RAPP | Rapport Therapeutics, Inc. | 1.35B | -6.01% | 284,730 | - |
| 133 | XERS | Xeris Biopharma Holdings, Inc. | 1.35B | 12.76% | 4,956,051 | 266.14M |
| 134 | CAPR | Capricor Therapeutics, Inc. | 1.32B | -2.89% | 854,655 | 11.13M |
| 135 | ORKA | Oruka Therapeutics, Inc. | 1.28B | -5.07% | 334,138 | - |
| 136 | OCS | Oculis Holding AG | 1.27B | 5.05% | 333,685 | 992.00K |
| 137 | IMTX | Immatics N.V. | 1.25B | -5.28% | 412,924 | 99.45M |
| 138 | ABCL | AbCellera Biologics Inc. | 1.23B | -0.48% | 4,804,064 | 35.33M |
| 139 | NTLA | Intellia Therapeutics, Inc. | 1.22B | 3.85% | 6,732,459 | 57.53M |
| 140 | ANAB | AnaptysBio, Inc. | 1.21B | -3.12% | 1,746,999 | 169.47M |
| 141 | PHAR | Pharming Group N.V. | 1.21B | 4.13% | 19,043 | 362.27M |
| 142 | SANA | Sana Biotechnology, Inc. | 1.20B | -4.44% | 2,835,651 | - |
| 143 | NVAX | Novavax, Inc. | 1.19B | -3.67% | 2,796,894 | 1.06B |
| 144 | NBY | NovaBay Pharmaceuticals, Inc. | 1.19B | -11.09% | 1,323,673 | 10.30M |
| 145 | PVLA | Palvella Therapeutics, Inc. | 1.15B | -3.61% | 203,075 | - |
| 146 | SEPN | Septerna, Inc. | 1.15B | -2.54% | 177,436 | 22.05M |
| 147 | PHAT | Phathom Pharmaceuticals, Inc. | 1.11B | -13.72% | 6,726,500 | 147.19M |
| 148 | URGN | UroGen Pharma Ltd. | 1.10B | 1.43% | 439,229 | 96.52M |
| 149 | INBX | Inhibrx Biosciences, Inc. | 1.09B | -0.96% | 147,553 | 1.40M |
| 150 | SPRY | ARS Pharmaceuticals, Inc. | 1.08B | -1.35% | 1,287,586 | 142.77M |
| 151 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 1.06B | 9.92% | 760,179 | - |
| 152 | IOVA | Iovance Biotherapeutics, Inc. | 1.04B | -5.78% | 10,758,517 | 250.43M |
| 153 | MLTX | MoonLake Immunotherapeutics | 1.02B | 27.02% | 24,534,418 | - |
| 154 | XNCR | Xencor, Inc. | 1.01B | -5.08% | 931,684 | 150.13M |
| 155 | VTYX | Ventyx Biosciences, Inc. | 987.60M | 0.80% | 36,115,875 | - |
| 156 | MRVI | Maravai LifeSciences Holdings, Inc. | 984.47M | -0.26% | 804,289 | 192.44M |
| 157 | NBTX | Nanobiotix S.A. | 981.00M | -7.03% | 43,817 | 11.93M |
| 158 | GHRS | GH Research PLC | 964.56M | -13.37% | 727,598 | - |
| 159 | TBPH | Theravance Biopharma, Inc. | 963.79M | 0.74% | 290,995 | 80.33M |
| 160 | OMER | Omeros Corporation | 953.61M | -4.54% | 4,966,925 | - |
| 161 | DAWN | Day One Biopharmaceuticals, Inc. | 949.75M | -3.75% | 1,480,071 | 133.67M |
| 162 | MDXG | MiMedx Group, Inc. | 934.52M | -2.02% | 809,705 | 393.44M |
| 163 | CMPX | Compass Therapeutics, Inc. | 919.55M | -5.14% | 1,780,778 | 850.00K |
| 164 | BCAX | Bicara Therapeutics Inc. | 907.19M | -3.55% | 423,352 | - |
| 165 | IVA | Inventiva S.A. | 907.19M | -3.53% | 342,904 | 19.93M |
| 166 | ABUS | Arbutus Biopharma Corporation | 894.31M | -4.71% | 1,366,915 | 14.61M |
| 167 | ZBIO | Zenas BioPharma, Inc. | 880.88M | -0.61% | 813,472 | 15.00M |
| 168 | GERN | Geron Corporation | 874.55M | - | 8,754,393 | 183.40M |
| 169 | YDES | YD Bio Limited | 867.04M | 7.22% | 116,309 | 510.36K |
| 170 | RAPT | RAPT Therapeutics, Inc. | 864.58M | -3.76% | 310,987 | - |
| 171 | NKTR | Nektar Therapeutics | 842.96M | -4.76% | 571,333 | 62.60M |
| 172 | VALN | Valneva SE | 840.34M | -1.42% | 13,373 | 211.09M |
| 173 | JANX | Janux Therapeutics, Inc. | 836.66M | -0.50% | 1,143,831 | 10.00M |
| 174 | KURA | Kura Oncology, Inc. | 831.02M | -4.21% | 1,423,529 | 104.03M |
| 175 | VIR | Vir Biotechnology, Inc. | 827.79M | -3.41% | 1,433,368 | 16.86M |
| 176 | ORIC | ORIC Pharmaceuticals, Inc. | 822.94M | -2.65% | 1,388,496 | - |
| 177 | AVBP | ArriVent BioPharma, Inc. | 809.94M | -0.10% | 233,594 | - |
| 178 | RIGL | Rigel Pharmaceuticals, Inc. | 807.73M | -5.38% | 720,205 | 282.08M |
| 179 | KALV | KalVista Pharmaceuticals, Inc. | 799.64M | -3.18% | 2,463,617 | 1.43M |
| 180 | ANNX | Annexon, Inc. | 788.51M | -4.34% | 2,425,238 | - |
| 181 | ARVN | Arvinas, Inc. | 782.25M | -1.85% | 596,952 | 312.30M |
| 182 | RGNX | REGENXBIO Inc. | 759.35M | -1.57% | 654,123 | 161.32M |
| 183 | MPLT | MapLight Therapeutics, Inc. | 750.20M | 7.04% | 112,569 | - |
| 184 | ATXS | Astria Therapeutics, Inc. | 740.96M | -1.67% | 412,484 | 706.00K |
| 185 | CTMX | CytomX Therapeutics, Inc. | 721.79M | -0.93% | 2,083,017 | 113.63M |
| 186 | PROK | ProKidney Corp. | 709.97M | -2.48% | 471,090 | 744.00K |
| 187 | IVVD | Invivyd, Inc. | 695.58M | 4.58% | 2,552,198 | 50.04M |
| 188 | PRME | Prime Medicine, Inc. | 693.99M | -2.97% | 2,249,947 | 5.98M |
| 189 | DBVT | DBV Technologies S.A. | 693.20M | -5.50% | 369,269 | 5.50M |
| 190 | LXEO | Lexeo Therapeutics, Inc. | 691.19M | -5.49% | 902,509 | - |
| 191 | GYRE | Gyre Therapeutics, Inc. | 688.04M | 3.56% | 101,871 | 107.27M |
| 192 | DRUG | Bright Minds Biosciences Inc. | 672.50M | -6.23% | 975,330 | - |
| 193 | FULC | Fulcrum Therapeutics, Inc. | 666.96M | 1.30% | 926,011 | 80.00M |
| 194 | CGEM | Cullinan Therapeutics, Inc. | 658.11M | 1.83% | 876,676 | - |
| 195 | REPL | Replimune Group, Inc. | 645.59M | -7.74% | 1,134,287 | - |
| 196 | JBIO | Jade Biosciences, Inc. | 609.56M | 0.45% | 228,568 | - |
| 197 | VSTM | Verastem, Inc. | 607.42M | 3.01% | 3,062,670 | 13.38M |
| 198 | CRMD | CorMedix Inc. | 591.71M | -32.77% | 23,663,963 | 214.30M |
| 199 | MGTX | MeiraGTx Holdings plc | 585.97M | -5.82% | 438,615 | 27.42M |
| 200 | GOSS | Gossamer Bio, Inc. | 578.64M | 3.73% | 7,125,030 | 44.05M |
| 201 | EVMN | Evommune, Inc. | 574.68M | 12.53% | 551,197 | 13.00M |
| 202 | ENGN | enGene Holdings Inc. | 569.37M | - | 89,405 | - |
| 203 | KROS | Keros Therapeutics, Inc. | 566.06M | 0.11% | 529,681 | 246.72M |
| 204 | SLS | SELLAS Life Sciences Group, Inc. | 549.83M | -4.46% | 11,248,974 | - |
| 205 | DRTS | Alpha Tau Medical Ltd. | 546.54M | 8.64% | 929,621 | - |
| 206 | TENX | Tenax Therapeutics, Inc. | 532.28M | 2.10% | 283,232 | - |
| 207 | LBRX | LB Pharmaceuticals Inc | 526.22M | -0.91% | 154,461 | - |
| 208 | NAGE | Niagen Bioscience, Inc. | 525.38M | -0.15% | 647,946 | 124.71M |
| 209 | DSGN | Design Therapeutics, Inc. | 522.93M | -6.99% | 245,753 | - |
| 210 | ABSI | Absci Corporation | 517.28M | -14.43% | 7,402,430 | 2.82M |
| 211 | CRVS | Corvus Pharmaceuticals, Inc. | 516.80M | -2.54% | 1,642,932 | - |
| 212 | LYEL | Lyell Immunopharma, Inc. | 516.23M | -2.99% | 117,624 | 41.00K |
| 213 | DNA | Ginkgo Bioworks Holdings, Inc. | 514.94M | -5.72% | 654,932 | 180.61M |
| 214 | VTVT | vTv Therapeutics Inc. | 509.51M | -2.21% | 15,515 | 17.00K |
| 215 | AUTL | Autolus Therapeutics plc | 508.33M | -2.05% | 1,261,830 | 51.13M |
| 216 | ASMB | Assembly Biosciences, Inc. | 499.19M | 0.54% | 167,103 | 37.19M |
| 217 | VOR | Vor Biopharma Inc. | 494.84M | -5.75% | 807,214 | - |
| 218 | ANRO | Alto Neuroscience, Inc. | 493.64M | -0.69% | 170,870 | - |
| 219 | PRTA | Prothena Corporation plc | 487.16M | -0.88% | 375,981 | 11.79M |
| 220 | ZVRA | Zevra Therapeutics, Inc. | 485.85M | 1.77% | 741,029 | 84.39M |
| 221 | KYTX | Kyverna Therapeutics, Inc. | 482.74M | -2.87% | 818,951 | - |
| 222 | LENZ | LENZ Therapeutics, Inc. | 476.86M | -6.56% | 2,163,047 | 17.50M |
| 223 | OCGN | Ocugen, Inc. | 465.36M | -6.29% | 3,768,428 | 5.37M |
| 224 | PEPG | PepGen Inc. | 463.36M | -5.73% | 442,655 | - |
| 225 | BCYC | Bicycle Therapeutics plc | 459.91M | -3.49% | 196,369 | 28.34M |
| 226 | ALT | Altimmune, Inc. | 445.35M | -2.63% | 3,830,737 | 20.00K |
| 227 | ADCT | ADC Therapeutics SA | 442.24M | -2.19% | 382,800 | 75.21M |
| 228 | NBP | NovaBridge Biosciences | 436.95M | -5.25% | 1,270,265 | - |
| 229 | DMAC | DiaMedica Therapeutics Inc. | 434.85M | -1.65% | 115,056 | - |
| 230 | EPRX | Eupraxia Pharmaceuticals Inc. | 434.30M | 19.14% | 773,870 | - |
| 231 | VNDA | Vanda Pharmaceuticals Inc. | 433.77M | -14.05% | 3,674,994 | 212.07M |
| 232 | FBRX | Forte Biosciences, Inc. | 431.16M | -8.06% | 113,162 | - |
| 233 | IMMP | Immutep Limited | 428.84M | -1.97% | 204,066 | 3.31M |
| 234 | LXRX | Lexicon Pharmaceuticals, Inc. | 428.81M | 0.85% | 1,202,194 | 70.86M |
| 235 | LCTX | Lineage Cell Therapeutics, Inc. | 426.50M | -3.83% | 836,890 | 10.82M |
| 236 | MNPR | Monopar Therapeutics Inc. | 423.68M | -2.48% | 197,745 | - |
| 237 | RCKT | Rocket Pharmaceuticals, Inc. | 419.90M | -0.26% | 1,813,302 | - |
| 238 | FDMT | 4D Molecular Therapeutics, Inc. | 417.09M | -6.05% | 973,343 | 120.00K |
| 239 | PRTC | PureTech Health plc | 416.82M | 1.02% | 2,252 | 6.39M |
| 240 | SLDB | Solid Biosciences Inc. | 413.70M | -5.35% | 873,961 | - |
| 241 | BNTC | Benitec Biopharma Inc. | 412.44M | 0.33% | 74,455 | - |
| 242 | TECX | Tectonic Therapeutic, Inc. | 401.65M | -1.29% | 193,908 | - |
| 243 | NMRA | Neumora Therapeutics, Inc. | 395.96M | 1.75% | 2,953,937 | - |
| 244 | ENTA | Enanta Pharmaceuticals, Inc. | 387.91M | -3.24% | 229,742 | 65.32M |
| 245 | AVXL | Anavex Life Sciences Corp. | 381.52M | 4.15% | 1,270,680 | - |
| 246 | TRDA | Entrada Therapeutics, Inc. | 377.26M | -2.14% | 134,555 | 61.52M |
| 247 | XOMA | XOMA Royalty Corporation | 370.50M | 9.96% | 748,502 | 47.11M |
| 248 | HELP | Cybin Inc. | 367.79M | 1.24% | 301,583 | - |
| 249 | XFOR | X4 Pharmaceuticals, Inc. | 353.24M | 1.00% | 352,418 | 33.98M |
| 250 | ZURA | Zura Bio Limited | 342.02M | -0.38% | 353,017 | - |
| 251 | ACIU | AC Immune SA | 340.36M | -6.52% | 244,476 | 5.48M |
| 252 | ALLO | Allogene Therapeutics, Inc. | 334.85M | - | 3,089,528 | 22.00K |
| 253 | CLLS | Cellectis S.A. | 332.51M | -1.54% | 63,312 | 82.55M |
| 254 | AURA | Aura Biosciences, Inc. | 327.68M | -4.97% | 162,223 | - |
| 255 | RLMD | Relmada Therapeutics, Inc. | 324.87M | 2.55% | 410,847 | - |
| 256 | CAMP | Camp4 Therapeutics Corporation | 321.66M | - | 167,312 | 3.80M |
| 257 | AARD | Aardvark Therapeutics, Inc. | 315.93M | 5.91% | 143,637 | - |
| 258 | PBYI | Puma Biotechnology, Inc. | 312.42M | 1.81% | 374,273 | 212.00M |
| 259 | GLSI | Greenwich LifeSciences, Inc. | 310.48M | -10.29% | 263,738 | - |
| 260 | AVTX | Avalo Therapeutics, Inc. | 310.27M | 1.00% | 450,060 | 192.00K |
| 261 | MENS | Jyong Biotech Ltd. | 307.60M | -3.15% | 238,551 | - |
| 262 | IMRX | Immuneering Corporation | 305.42M | -43.22% | 17,564,056 | - |
| 263 | CADL | Candel Therapeutics, Inc. | 304.69M | -2.12% | 478,647 | - |
| 264 | TARA | Protara Therapeutics, Inc. | 300.62M | -1.41% | 931,121 | - |
| 265 | FHTX | Foghorn Therapeutics Inc. | 295.76M | -0.57% | 173,746 | 24.52M |
| 266 | STTK | Shattuck Labs, Inc. | 293.62M | -3.33% | 852,784 | 1.00M |
| 267 | ACHV | Achieve Life Sciences, Inc. | 291.19M | 5.19% | 1,080,516 | - |
| 268 | ACRS | Aclaris Therapeutics, Inc. | 290.37M | - | 771,060 | 15.74M |
| 269 | NGNE | Neurogene Inc. | 289.35M | -2.30% | 81,082 | 925.00K |
| 270 | GUTS | Fractyl Health, Inc. | 287.79M | 0.48% | 3,936,589 | 3.00K |
| 271 | LRMR | Larimar Therapeutics, Inc. | 287.58M | -1.75% | 680,406 | - |
| 272 | ARMP | Armata Pharmaceuticals, Inc. | 287.25M | 18.11% | 111,077 | 5.05M |
| 273 | PALI | Palisade Bio, Inc. | 283.11M | -5.94% | 4,516,595 | - |
| 274 | AVIR | Atea Pharmaceuticals, Inc. | 282.04M | 3.74% | 367,215 | - |
| 275 | NAUT | Nautilus Biotechnology, Inc. | 280.40M | - | 213,877 | - |
| 276 | ABEO | Abeona Therapeutics Inc. | 275.83M | -2.49% | 1,652,053 | 400.00K |
| 277 | SLN | Silence Therapeutics plc | 273.96M | - | 592,926 | 25.83M |
| 278 | OBIO | Orchestra BioMed Holdings, Inc. | 273.29M | 1.04% | 218,530 | 2.82M |
| 279 | OABI | OmniAb, Inc. | 272.08M | -0.53% | 276,225 | 21.09M |
| 280 | IMMX | Immix Biopharma, Inc. | 268.22M | 0.79% | 1,265,977 | - |
| 281 | CTNM | Contineum Therapeutics, Inc. | 267.60M | -4.08% | 364,957 | - |
| 282 | FENC | Fennec Pharmaceuticals Inc. | 258.88M | -0.26% | 75,083 | 38.79M |
| 283 | ALDX | Aldeyra Therapeutics, Inc. | 251.48M | 0.48% | 548,795 | - |
| 284 | MDWD | MediWound Ltd. | 247.45M | -0.36% | 89,991 | 20.93M |
| 285 | HRTX | Heron Therapeutics, Inc. | 232.87M | 0.79% | 1,167,992 | 155.10M |
| 286 | IKT | Inhibikase Therapeutics, Inc. | 228.43M | -11.64% | 667,049 | 1.00 |
| 287 | PRLD | Prelude Therapeutics Incorporated | 227.42M | -2.47% | 356,495 | 10.50M |
| 288 | NVCT | Nuvectis Pharma, Inc. | 226.69M | 0.68% | 198,512 | - |
| 289 | HUMA | Humacyte, Inc. | 225.81M | -2.50% | 4,704,022 | 1.57M |
| 290 | VYGR | Voyager Therapeutics, Inc. | 225.74M | -0.73% | 384,973 | 31.32M |
| 291 | OVID | Ovid Therapeutics Inc. | 225.22M | -2.81% | 1,139,633 | 6.61M |
| 292 | MIST | Milestone Pharmaceuticals Inc. | 222.47M | 1.86% | 2,715,211 | - |
| 293 | PRQR | ProQR Therapeutics N.V. | 221.22M | -2.78% | 657,606 | 18.86M |
| 294 | RZLT | Rezolute, Inc. | 219.76M | 0.85% | 9,764,550 | - |
| 295 | CLYM | Climb Bio, Inc. | 218.67M | 9.05% | 1,400,656 | - |
| 296 | CBIO | Crescent Biopharma, Inc. | 214.46M | 0.27% | 105,197 | - |
| 297 | CRDF | Cardiff Oncology, Inc. | 213.53M | -1.25% | 1,359,832 | 501.00K |
| 298 | CCCC | C4 Therapeutics, Inc. | 212.24M | -1.35% | 1,078,164 | 30.11M |
| 299 | RNAC | Cartesian Therapeutics, Inc. | 211.15M | 4.64% | 192,449 | 1.09M |
| 300 | EDIT | Editas Medicine, Inc. | 208.90M | -0.93% | 1,232,844 | 46.38M |
| 301 | CABA | Cabaletta Bio, Inc. | 208.90M | 1.40% | 1,386,730 | - |
| 302 | GALT | Galectin Therapeutics Inc. | 206.31M | -9.60% | 659,916 | - |
| 303 | NERV | Minerva Neurosciences, Inc. | 203.39M | -0.21% | 63,025 | - |
| 304 | ENLV | Enlivex Therapeutics Ltd. | 198.90M | 1.92% | 180,310 | - |
| 305 | ALEC | Alector, Inc. | 193.20M | 0.57% | 1,001,239 | 69.05M |
| 306 | ARCT | Arcturus Therapeutics Holdings Inc. | 192.36M | -1.02% | 444,900 | 97.60M |
| 307 | NTHI | NeOnc Technologies Holdings, Inc. | 191.43M | 8.38% | 143,592 | 59.99K |
| 308 | TNXP | Tonix Pharmaceuticals Holding Corp. | 187.98M | -2.94% | 232,610 | 10.30M |
| 309 | CHRS | Coherus Oncology, Inc. | 184.93M | 6.99% | 2,311,742 | 277.73M |
| 310 | ZNTL | Zentalis Pharmaceuticals, Inc. | 183.89M | 17.36% | 7,091,564 | 26.87M |
| 311 | SABS | SAB Biotherapeutics, Inc. | 183.76M | -2.77% | 1,023,236 | 114.70K |
| 312 | SGMT | Sagimet Biosciences Inc. | 181.15M | 0.91% | 378,997 | - |
| 313 | TLSA | Tiziana Life Sciences Ltd | 175.86M | -1.33% | 159,428 | - |
| 314 | RANI | Rani Therapeutics Holdings, Inc. | 168.91M | - | 1,342,838 | 1.20M |
| 315 | IPHA | Innate Pharma S.A. | 164.57M | -1.69% | 5,393 | 14.84M |
| 316 | SRZN | Surrozen, Inc. | 163.37M | -4.56% | 43,314 | 3.60M |
| 317 | PLX | Protalix BioTherapeutics, Inc. | 160.84M | 12.36% | 3,821,108 | 61.84M |
| 318 | BDTX | Black Diamond Therapeutics, Inc. | 158.39M | 2.58% | 952,933 | 70.00M |
| 319 | CRBU | Caribou Biosciences, Inc. | 157.96M | -4.52% | 492,944 | 9.30M |
| 320 | SLGL | Sol-Gel Technologies Ltd. | 155.11M | 4.58% | 14,123 | 18.97M |
| 321 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 154.90M | -0.71% | 118,692 | - |
| 322 | MOLN | Molecular Partners AG | 154.88M | -0.28% | 17,064 | 856.30K |
| 323 | IPSC | Century Therapeutics, Inc. | 154.54M | 36.15% | 19,559,538 | 113.34M |
| 324 | KLRS | Kalaris Therapeutics, Inc. | 154.48M | -5.71% | 45,258 | - |
| 325 | CGEN | Compugen Ltd. | 153.40M | -4.65% | 354,408 | 6.90M |
| 326 | CDXS | Codexis, Inc. | 151.74M | -1.18% | 502,106 | 52.93M |
| 327 | SGMO | Sangamo Therapeutics, Inc. | 151.49M | -2.13% | 3,737,713 | 32.88M |
| 328 | NKTX | Nkarta, Inc. | 149.87M | 2.43% | 1,580,314 | - |
| 329 | KPTI | Karyopharm Therapeutics Inc. | 149.60M | 3.81% | 518,569 | 142.53M |
| 330 | QNCX | Quince Therapeutics, Inc. | 149.23M | -7.90% | 618,295 | - |
| 331 | CNTX | Context Therapeutics Inc. | 147.01M | -3.61% | 1,882,298 | - |
| 332 | ACTU | Actuate Therapeutics, Inc. | 145.97M | -3.24% | 62,049 | - |
| 333 | SPRO | Spero Therapeutics, Inc. | 144.79M | -1.15% | 284,006 | 40.55M |
| 334 | ELTX | Elicio Therapeutics, Inc. | 143.99M | -0.72% | 145,162 | - |
| 335 | ACOG | Alpha Cognition Inc. | 142.63M | 0.92% | 24,541 | 7.43M |
| 336 | MCRB | Seres Therapeutics, Inc. | 139.77M | -2.59% | 28,915 | 351.00K |
| 337 | ORMP | Oramed Pharmaceuticals Inc. | 138.51M | 6.42% | 329,977 | 2.00M |
| 338 | IRD | Opus Genetics, Inc. | 137.93M | -5.21% | 433,336 | 14.63M |
| 339 | TTRX | Turn Therapeutics Inc. | 136.92M | 1.75% | 14,629 | - |
| 340 | FBIO | Fortress Biotech, Inc. | 135.95M | 2.58% | 859,571 | 62.30M |
| 341 | UNCY | Unicycive Therapeutics, Inc. | 131.53M | 1.83% | 509,191 | - |
| 342 | ELDN | Eledon Pharmaceuticals, Inc. | 130.01M | 1.17% | 591,929 | - |
| 343 | HYFT | MindWalk Holdings Corp. | 129.80M | 4.12% | 700,425 | 19.02M |
| 344 | TNYA | Tenaya Therapeutics, Inc. | 128.54M | -3.51% | 3,299,941 | - |
| 345 | VRCA | Verrica Pharmaceuticals Inc. | 128.24M | -1.23% | 111,292 | 30.83M |
| 346 | WHWK | Whitehawk Therapeutics, Inc. | 127.72M | 1.50% | 82,654 | 14.38M |
| 347 | AGEN | Agenus Inc. | 127.53M | 1.35% | 666,372 | 106.83M |
| 348 | CGTX | Cognition Therapeutics, Inc. | 126.23M | -3.38% | 609,914 | - |
| 349 | ATRA | Atara Biotherapeutics, Inc. | 125.75M | 16.73% | 417,943 | 151.93M |
| 350 | CNTB | Connect Biopharma Holdings Limited | 124.66M | -5.11% | 83,339 | 762.00K |
| 351 | FATE | Fate Therapeutics, Inc. | 122.27M | -4.50% | 1,479,564 | 7.14M |
| 352 | MGNX | MacroGenics, Inc. | 113.23M | -1.10% | 604,175 | 127.63M |
| 353 | ABOS | Acumen Pharmaceuticals, Inc. | 112.67M | -6.53% | 588,282 | - |
| 354 | ANIX | Anixa Biosciences, Inc. | 112.58M | 4.27% | 354,100 | - |
| 355 | ARTV | Artiva Biotherapeutics, Inc. | 112.42M | -0.43% | 135,241 | 251.00K |
| 356 | CBUS | Cibus, Inc. | 111.28M | -17.34% | 540,992 | 3.79M |
| 357 | INO | Inovio Pharmaceuticals, Inc. | 110.61M | -3.59% | 1,021,805 | 182.34K |
| 358 | VXRT | Vaxart, Inc. | 109.77M | 9.52% | - | 148.20M |
| 359 | RPTX | Repare Therapeutics Inc. | 109.06M | -1.17% | 3,105,317 | 11.87M |
| 360 | COYA | Coya Therapeutics, Inc. | 107.13M | -0.58% | 386,174 | 3.99M |
| 361 | ONCY | Oncolytics Biotech Inc. | 106.70M | 3.23% | 544,796 | - |
| 362 | THAR | Tharimmune, Inc. | 106.05M | -3.32% | 405,351 | - |
| 363 | SEER | Seer, Inc. | 105.19M | -1.06% | 233,572 | 16.38M |
| 364 | ANVS | Annovis Bio, Inc. | 103.89M | -3.69% | 296,019 | - |
| 365 | SAVA | Cassava Sciences, Inc. | 103.38M | -1.83% | 599,269 | - |
| 366 | GNLX | Genelux Corporation | 102.32M | -19.76% | 1,881,178 | 8.00K |
| 367 | STRO | Sutro Biopharma, Inc. | 100.10M | - | 155,920 | 105.65M |
| 368 | DTIL | Precision BioSciences, Inc. | 97.01M | -7.57% | 251,503 | 698.00K |
| 369 | VANI | Vivani Medical, Inc. | 95.57M | 1.55% | 117,594 | - |
| 370 | BMEA | Biomea Fusion, Inc. | 94.74M | 0.75% | 787,572 | - |
| 371 | CSBR | Champions Oncology, Inc. | 94.30M | 0.61% | 3,856 | 58.42M |
| 372 | GANX | Gain Therapeutics, Inc. | 93.85M | 1.24% | 827,427 | - |
| 373 | DWTX | Dogwood Therapeutics, Inc. | 93.64M | -11.52% | 140,478 | - |
| 374 | ETHZ | ETHZilla Corporation | 92.78M | -2.40% | 550,604 | 4.11M |
| 375 | PYXS | Pyxis Oncology, Inc. | 90.28M | 2.11% | 759,247 | 2.82M |
| 376 | OKYO | OKYO Pharma Limited | 87.26M | 3.11% | 22,574 | - |
| 377 | PTHS | Pelthos Therapeutics Inc. | 86.61M | 0.21% | 17,982 | 7.41M |
| 378 | KRRO | Korro Bio, Inc. | 86.17M | 7.77% | 276,950 | 7.37M |
| 379 | ATOS | Atossa Therapeutics, Inc. | 84.35M | -1.82% | 903,874 | - |
| 380 | ACET | Adicet Bio, Inc. | 81.76M | -4.26% | 170,489 | - |
| 381 | EXOZ | eXoZymes, Inc. | 81.19M | -2.22% | 4,024 | -700.00 |
| 382 | XBIT | XBiotech Inc. | 80.79M | 5.58% | 165,024 | - |
| 383 | PLRX | Pliant Therapeutics, Inc. | 80.50M | -2.96% | 869,904 | - |
| 384 | PSTV | Plus Therapeutics, Inc. | 80.41M | -3.73% | 3,470,788 | 5.26M |
| 385 | ENTX | Entera Bio Ltd. | 79.79M | 9.43% | 395,592 | 124.00K |
| 386 | IMUX | Immunic, Inc. | 79.71M | -3.96% | 1,527,886 | - |
| 387 | SPRB | Spruce Biosciences, Inc. | 78.89M | -5.62% | 60,800 | 697.00K |
| 388 | COEP | Coeptis Therapeutics Holdings, Inc. | 78.50M | -3.61% | 66,694 | 501.00K |
| 389 | ADAG | Adagene Inc. | 77.77M | -1.79% | 61,280 | 103.20K |
| 390 | TVGN | Tevogen Bio Holdings Inc. | 77.49M | 0.96% | 556,266 | - |
| 391 | PYPD | PolyPid Ltd. | 77.35M | -2.52% | 124,119 | - |
| 392 | CALC | CalciMedica, Inc. | 76.80M | -7.79% | 60,583 | - |
| 393 | KZIA | Kazia Therapeutics Limited | 73.88M | 1.50% | 131,004 | 1.20M |
| 394 | IFRX | InflaRx N.V. | 73.84M | -9.17% | 408,462 | 73.73K |
| 395 | IMA | ImageneBio, Inc. | 72.96M | 1.18% | 6,668 | 800.00K |
| 396 | CRVO | CervoMed Inc. | 72.82M | -1.01% | 57,103 | 6.16M |
| 397 | ATYR | aTyr Pharma, Inc. | 71.05M | -2.87% | 1,349,031 | 190.00K |
| 398 | MNOV | MediciNova, Inc. | 69.79M | 1.43% | 90,972 | 257.92K |
| 399 | NRXP | NRx Pharmaceuticals, Inc. | 68.98M | -4.90% | 482,426 | 242.00K |
| 400 | EQ | Equillium, Inc. | 68.81M | -13.74% | 850,877 | 4.39M |
| 401 | ALXO | ALX Oncology Holdings Inc. | 67.23M | 5.08% | 312,602 | - |
| 402 | TCRX | TScan Therapeutics, Inc. | 66.96M | - | 523,580 | 8.42M |
| 403 | MGX | Metagenomi, Inc. | 66.46M | -1.67% | 190,577 | 30.91M |
| 404 | BYSI | BeyondSpring Inc. | 65.38M | 3.92% | 36,914 | 1.88M |
| 405 | ALGS | Aligos Therapeutics, Inc. | 63.57M | 7.05% | 88,859 | 2.65M |
| 406 | MAIA | MAIA Biotechnology, Inc. | 63.52M | 1.84% | 409,499 | - |
| 407 | PMVP | PMV Pharmaceuticals, Inc. | 63.32M | -3.64% | 323,158 | - |
| 408 | MREO | Mereo BioPharma Group plc | 61.17M | -8.87% | 21,976,800 | 500.00K |
| 409 | ACRV | Acrivon Therapeutics, Inc. | 60.90M | -34.58% | 42,740,859 | - |
| 410 | ICCC | ImmuCell Corporation | 59.43M | 5.29% | 38,376 | 27.77M |
| 411 | RADX | Radiopharm Theranostics Limited | 59.27M | -1.44% | 45,916 | 8.20M |
| 412 | GRCE | Grace Therapeutics, Inc. | 58.80M | 1.88% | 260,541 | - |
| 413 | PASG | Passage Bio, Inc. | 58.27M | 1.61% | 63,376 | - |
| 414 | INKT | MiNK Therapeutics, Inc. | 58.21M | -1.74% | 10,298 | - |
| 415 | ATHE | Alterity Therapeutics Limited | 58.20M | 3.74% | 11,897 | 3.57M |
| 416 | LITS | Lite Strategy, Inc. | 54.79M | 4.93% | 294,690 | - |
| 417 | PDSB | PDS Biotechnology Corporation | 54.35M | 4.23% | 902,694 | - |
| 418 | ANL | Adlai Nortye Ltd. | 54.24M | 2.80% | 68,554 | -1.35M |
| 419 | OSTX | OS Therapies Incorporated | 54.23M | 0.65% | 880,538 | - |
| 420 | NTRB | Nutriband Inc. | 53.73M | -2.43% | 19,708 | 2.28M |
| 421 | ESLA | Estrella Immunopharma, Inc. | 53.63M | -1.39% | 45,803 | - |
| 422 | ABVC | ABVC BioPharma, Inc. | 53.03M | -2.60% | 19,605 | 797.92K |
| 423 | IBO | Impact BioMedical Inc. | 52.94M | 0.80% | 22,382 | 25.00K |
| 424 | IBIO | iBio, Inc. | 52.85M | 8.29% | 1,923,860 | 500.00K |
| 425 | TIL | Instil Bio, Inc. | 50.12M | 2.92% | 436,905 | - |
| 426 | NRXS | NeurAxis, Inc. | 49.32M | 4.28% | 228,916 | 3.36M |
| 427 | CVM | CEL-SCI Corporation | 49.28M | 2.81% | 20,981 | - |
| 428 | ANEB | Anebulo Pharmaceuticals, Inc. | 48.89M | -1.65% | 10,459 | - |
| 429 | TELO | Telomir Pharmaceuticals, Inc. | 48.82M | -3.07% | 81,789 | - |
| 430 | APLM | Apollomics, Inc. | 48.33M | 8.27% | 30,049 | 6.93M |
| 431 | NXTC | NextCure, Inc. | 47.64M | -2.79% | 7,489 | - |
| 432 | KZR | Kezar Life Sciences, Inc. | 47.60M | 3.17% | 148,454 | - |
| 433 | PTN | Palatin Technologies, Inc. | 47.18M | -2.55% | 63,791 | 8.85M |
| 434 | JSPR | Jasper Therapeutics, Inc. | 46.45M | -19.02% | 5,813,172 | - |
| 435 | HURA | TuHURA Biosciences, Inc. | 45.81M | 0.99% | 221,134 | - |
| 436 | ATNM | Actinium Pharmaceuticals, Inc. | 44.61M | -2.05% | 59,293 | 90.00K |
| 437 | QTTB | Q32 Bio Inc. | 44.05M | 7.51% | 323,864 | - |
| 438 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 42.77M | 5.72% | 5,162,199 | - |
| 439 | EVAX | Evaxion A/S | 42.62M | -5.19% | 24,429 | 7.65M |
| 440 | RNXT | RenovoRx, Inc. | 42.15M | 13.86% | 1,296,636 | 928.00K |
| 441 | LPCN | Lipocine Inc. | 41.81M | 0.13% | 105,351 | 4.32M |
| 442 | INMB | INmune Bio, Inc. | 40.68M | -3.16% | 206,126 | 50.00K |
| 443 | IOBT | IO Biotech, Inc. | 40.36M | -12.02% | 1,415,798 | - |
| 444 | TVRD | Tvardi Therapeutics, Inc. | 39.68M | 8.74% | 192,118 | - |
| 445 | OKUR | OnKure Therapeutics, Inc. | 38.75M | 1.42% | 85,969 | - |
| 446 | OTLK | Outlook Therapeutics, Inc. | 38.74M | 2.42% | 6,270,439 | 1.41M |
| 447 | XLO | Xilio Therapeutics, Inc. | 37.98M | 2.60% | 323,290 | 31.80M |
| 448 | LTRN | Lantern Pharma Inc. | 37.92M | -0.59% | 14,621 | - |
| 449 | XCUR | Exicure, Inc. | 37.48M | 1.03% | 22,050 | 500.00K |
| 450 | GBIO | Generation Bio Co. | 37.13M | 0.73% | 42,957 | 15.27M |
| 451 | VERU | Veru Inc. | 37.08M | -2.53% | 97,704 | 16.89M |
| 452 | ANTX | AN2 Therapeutics, Inc. | 36.17M | 20.00% | 1,058,543 | - |
| 453 | CELU | Celularity Inc. | 35.88M | 1.61% | 33,705 | 40.58M |
| 454 | CUE | Cue Biopharma, Inc. | 35.85M | 1.52% | 544,412 | 7.10M |
| 455 | JUNS | Jupiter Neurosciences, Inc. | 35.46M | -1.44% | 67,992 | - |
| 456 | DYAI | Dyadic International, Inc. | 35.04M | -0.16% | 52,026 | 3.34M |
| 457 | MRKR | Marker Therapeutics, Inc. | 34.51M | -5.48% | 1,270,453 | 4.69M |
| 458 | CING | Cingulate Inc. | 34.33M | 2.21% | 618,846 | - |
| 459 | GNTA | Genenta Science S.p.A. | 33.74M | 2.13% | 62,413 | - |
| 460 | SKYE | Skye Bioscience, Inc. | 33.66M | -5.41% | 347,019 | - |
| 461 | LIXT | Lixte Biotechnology Holdings, Inc. | 32.67M | -4.82% | 72,999 | - |
| 462 | GLTO | Galecto, Inc. | 32.49M | -3.00% | 18,742 | - |
| 463 | RNTX | Rein Therapeutics Inc. | 32.07M | -0.81% | 52,702 | - |
| 464 | RLYB | Rallybio Corporation | 31.18M | 3.14% | 149,513 | 674.00K |
| 465 | BRNS | Barinthus Biotherapeutics plc | 30.95M | 4.54% | 69,969 | 14.97M |
| 466 | HOWL | Werewolf Therapeutics, Inc. | 30.59M | -1.73% | 154,812 | 1.14M |
| 467 | DARE | Daré Bioscience, Inc. | 29.58M | 5.08% | 125,019 | -57.13K |
| 468 | BOLD | Boundless Bio, Inc. | 29.32M | 2.34% | 205,179 | - |
| 469 | QNTM | Quantum BioPharma Ltd. | 29.20M | -4.47% | 62,783 | - |
| 470 | SNTI | Senti Biosciences, Inc. | 28.39M | -6.09% | 276,752 | - |
| 471 | ATHA | Athira Pharma, Inc. | 28.36M | -1.91% | 113,990 | - |
| 472 | IGC | IGC Pharma, Inc. | 28.32M | -0.81% | 301,893 | 1.11M |
| 473 | HYPD | Hyperion DeFi, Inc. | 28.20M | -3.09% | 162,299 | 345.32K |
| 474 | SER | Serina Therapeutics, Inc. | 27.94M | 8.26% | 403,338 | 116.00K |
| 475 | NRSN | NeuroSense Therapeutics Ltd. | 27.86M | 12.43% | 265,773 | - |
| 476 | VTGN | Vistagen Therapeutics, Inc. | 27.80M | -4.43% | 788,872 | 721.00K |
| 477 | PLUR | Pluri Inc. | 27.77M | 1.01% | 11,389 | 1.33M |
| 478 | PLRZ | Polyrizon Ltd. | 26.47M | 8.32% | 106,317 | - |
| 479 | NNVC | NanoViricides, Inc. | 26.10M | -2.42% | 180,689 | - |
| 480 | INTS | Intensity Therapeutics, Inc. | 26.07M | 8.47% | 1,448,902 | - |
| 481 | KLTO | Klotho Neurosciences, Inc. | 24.84M | 1.21% | 558,224 | - |
| 482 | BCAB | BioAtla, Inc. | 23.65M | -5.54% | 1,361,744 | 11.00M |
| 483 | LIMN | Liminatus Pharma, Inc. | 22.20M | -12.72% | 200,291 | - |
| 484 | FBLG | FibroBiologics, Inc. | 21.95M | -4.04% | 2,162,445 | - |
| 485 | NEUP | Neuphoria Therapeutics Inc. | 21.89M | 2.52% | 161,979 | 15.65M |
| 486 | CASI | CASI Pharmaceuticals, Inc. | 21.88M | 23.26% | 125,429 | 26.85M |
| 487 | LNAI | Lunai Bioworks Inc. | 21.33M | -4.19% | 92,946 | - |
| 488 | KTTA | Pasithea Therapeutics Corp. | 21.27M | -5.05% | 323,339 | - |
| 489 | ALLR | Allarity Therapeutics, Inc. | 20.66M | 2.59% | 131,077 | - |
| 490 | KAPA | Kairos Pharma, Ltd. | 20.20M | 16.88% | 752,393 | - |
| 491 | VYNE | VYNE Therapeutics Inc. | 18.94M | 2.28% | 710,656 | 524.00K |
| 492 | CTXR | Citius Pharmaceuticals, Inc. | 18.69M | -2.68% | 262,627 | - |
| 493 | MTVA | MetaVia Inc. | 18.45M | -4.41% | 17,133 | - |
| 494 | CVKD | Cadrenal Therapeutics, Inc. | 18.42M | 5.63% | 78,392 | - |
| 495 | CLGN | CollPlant Biotechnologies Ltd. | 18.40M | -1.37% | 1,686 | 2.48M |
| 496 | PMN | ProMIS Neurosciences, Inc. | 18.25M | 2.66% | 12,885 | - |
| 497 | LSTA | Lisata Therapeutics, Inc. | 18.17M | -2.37% | 53,252 | 1.07M |
| 498 | ITRM | Iterum Therapeutics plc | 18.13M | -4.35% | 411,876 | 390.00K |
| 499 | LEXX | Lexaria Bioscience Corp. | 17.30M | -0.43% | 251,877 | 705.92K |
| 500 | HOTH | Hoth Therapeutics, Inc. | 16.91M | 5.77% | 123,579 | - |
| 501 | OSRH | OSR Holdings, Inc. | 15.97M | -1.11% | 265,009 | -90.52K |
| 502 | APLT | Applied Therapeutics, Inc. | 15.28M | -5.92% | 5,621,443 | 1.00M |
| 503 | GRDX | GridAI Technologies Corp. | 15.20M | -8.32% | 96,332 | - |
| 504 | COCP | Cocrystal Pharma, Inc. | 15.16M | - | 33,311 | - |
| 505 | GDTC | CytoMed Therapeutics Limited | 15.12M | -5.76% | 20,466 | 573.19K |
| 506 | KALA | KALA BIO, Inc. | 15.09M | -2.41% | 1,475,435 | - |
| 507 | NCNA | NuCana plc | 14.98M | -0.55% | 17,873 | - |
| 508 | SNGX | Soligenix, Inc. | 14.52M | -1.37% | 193,547 | 2.34K |
| 509 | SYBX | Synlogic, Inc. | 14.27M | 3.39% | 12,823 | 8.00K |
| 510 | TPST | Tempest Therapeutics, Inc. | 14.19M | 2.49% | 98,660 | - |
| 511 | CLRB | Cellectar Biosciences, Inc. | 14.03M | -0.30% | 11,208 | - |
| 512 | BCDA | BioCardia, Inc. | 14.01M | 0.76% | 72,313 | 3.00K |
| 513 | SNSE | Sensei Biotherapeutics, Inc. | 13.95M | -1.43% | 39,394 | - |
| 514 | BCTX | BriaCell Therapeutics Corp. | 13.63M | 2.10% | 105,454 | - |
| 515 | LGVN | Longeveron Inc. | 13.42M | 1.85% | 169,354 | 1.44M |
| 516 | IMNN | Imunon, Inc. | 13.13M | -1.53% | 36,142 | - |
| 517 | AKTX | Akari Therapeutics, Plc | 12.93M | -1.74% | 511,353 | - |
| 518 | AEON | AEON Biopharma, Inc. | 12.90M | -7.63% | 214,899 | - |
| 519 | PHIO | Phio Pharmaceuticals Corp. | 12.81M | -1.65% | 185,196 | - |
| 520 | MBRX | Moleculin Biotech, Inc. | 12.66M | 0.98% | 109,934 | - |
| 521 | EDSA | Edesa Biotech, Inc. | 12.58M | -1.95% | 20,813 | - |
| 522 | BLRX | BioLineRx Ltd. | 12.33M | 2.41% | 16,385 | 12.74M |
| 523 | TRAW | Traws Pharma, Inc. | 11.27M | 5.22% | 80,717 | 2.85M |
| 524 | BOLT | Bolt Biotherapeutics, Inc. | 11.15M | -2.02% | 5,031 | 5.20M |
| 525 | INAB | IN8bio, Inc. | 11.12M | -4.00% | 247,378 | - |
| 526 | ASBP | Aspire Biopharma Holdings, Inc. | 11.10M | -17.75% | 90,032,968 | 1.94K |
| 527 | CMMB | Chemomab Therapeutics Ltd. | 11.08M | -5.26% | 54,382 | - |
| 528 | QNRX | Quoin Pharmaceuticals, Ltd. | 11.03M | -4.36% | 42,207 | - |
| 529 | ABP | Abpro Holdings, Inc. | 11.03M | -8.76% | 24,943 | 183.00K |
| 530 | CRIS | Curis, Inc. | 10.99M | 1.15% | 1,454,094 | 11.65M |
| 531 | ERNA | Ernexa Therapeutics Inc. | 10.91M | 12.10% | 118,542 | 1,000.00 |
| 532 | BRTX | BioRestorative Therapies, Inc. | 10.65M | 1.69% | 25,089 | 383.40K |
| 533 | NCEL | NewcelX Ltd. | 10.07M | -4.33% | 48,267 | - |
| 534 | EVGN | Evogene Ltd. | 9.90M | -3.07% | 29,251 | 8.02M |
| 535 | BIVI | BioVie Inc. | 9.80M | -3.70% | 121,424 | - |
| 536 | PMCB | PharmaCyte Biotech, Inc. | 9.33M | 10.95% | 1,271,468 | - |
| 537 | ALZN | Alzamend Neuro, Inc. | 8.90M | - | 41,779 | - |
| 538 | APM | Aptorum Group Limited | 8.80M | 1.89% | 37,672 | - |
| 539 | ICU | SeaStar Medical Holding Corporation | 8.69M | -2.03% | 57,193 | 881.00K |
| 540 | APVO | Aptevo Therapeutics Inc. | 8.61M | 3.25% | 82,413 | - |
| 541 | PULM | Pulmatrix, Inc. | 8.58M | 2.17% | 24,652 | 3.00K |
| 542 | CELZ | Creative Medical Technology Holdings, Inc. | 8.56M | 2.51% | 57,512 | 6.00K |
| 543 | CLDI | Calidi Biotherapeutics, Inc. | 8.49M | - | 31,652 | - |
| 544 | MBIO | Mustang Bio, Inc. | 8.32M | 0.88% | 97,604 | - |
| 545 | ADXN | Addex Therapeutics Ltd | 8.08M | -1.76% | 3,729 | 198.82K |
| 546 | KPRX | Kiora Pharmaceuticals, Inc. | 8.01M | -0.23% | 28,927 | 20.00K |
| 547 | GOVX | GeoVax Labs, Inc. | 7.94M | -9.23% | 3,239,981 | 3.35M |
| 548 | TCRT | Alaunos Therapeutics, Inc. | 7.90M | 9.26% | 162,224 | 6.00K |
| 549 | PCSA | Processa Pharmaceuticals, Inc. | 7.84M | 0.73% | 73,540 | - |
| 550 | IMRN | Immuron Limited | 7.84M | -4.65% | 10,562 | 4.78M |
| 551 | TOVX | Theriva Biologics, Inc. | 7.40M | -1.48% | 2,219,124 | - |
| 552 | CYCN | Cyclerion Therapeutics, Inc. | 7.35M | 7.22% | 887,426 | 2.86M |
| 553 | RNAZ | TransCode Therapeutics, Inc. | 7.27M | 6.16% | 42,707 | - |
| 554 | GTBP | GT Biopharma, Inc. | 7.23M | -7.14% | 1,434,502 | - |
| 555 | PPBT | Purple Biotech Ltd | 7.02M | 1.17% | 84,189 | - |
| 556 | ACXP | Acurx Pharmaceuticals, Inc. | 6.86M | 0.34% | 60,549 | - |
| 557 | LYRA | Lyra Therapeutics, Inc. | 6.74M | 5.26% | 6,686 | 600.00K |
| 558 | BGMS | Bio Green Med Solution, Inc. | 6.66M | 0.74% | 11,566 | 81.00K |
| 559 | APRE | Aprea Therapeutics, Inc. | 6.57M | 4.46% | 129,976 | 488.24K |
| 560 | SLXN | Silexion Therapeutics Corp | 6.57M | - | 24,775 | - |
| 561 | XTLB | XTL Biopharmaceuticals Ltd. | 6.55M | 4.68% | 69,925 | 968.00K |
| 562 | PPCB | Propanc Biopharma, Inc. | 6.42M | -6.01% | 199,838 | - |
| 563 | ADIL | Adial Pharmaceuticals, Inc. | 6.22M | -1.48% | 274,683 | - |
| 564 | CANF | Can-Fite BioPharma Ltd. | 5.94M | -7.43% | 99,916 | 560.00K |
| 565 | VIVS | VivoSim Labs, Inc. | 5.42M | -6.73% | 73,238 | 140.00K |
| 566 | REVB | Revelation Biosciences, Inc. | 5.33M | -1.11% | 54,830 | - |
| 567 | INDP | Indaptus Therapeutics, Inc. | 5.25M | 11.52% | 211,838 | - |
| 568 | SILO | Silo Pharma, Inc. | 5.18M | 1.86% | 66,039 | 72.10K |
| 569 | XBIO | Xenetic Biosciences, Inc. | 5.01M | 0.80% | 19,540 | 2.86M |
| 570 | SPRC | SciSparc Ltd. | 4.95M | - | 70,159 | 1.31M |
| 571 | DCOY | Decoy Therapeutics Inc. | 4.92M | -8.33% | 282,079 | - |
| 572 | JAGX | Jaguar Health, Inc. | 4.90M | -0.92% | 240,313 | 11.79M |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 4.66M | 1.87% | 24,314 | - |
| 574 | MTNB | Matinas BioPharma Holdings, Inc. | 4.65M | 8.30% | 14,726 | - |
| 575 | GNPX | Genprex, Inc. | 4.64M | 5.82% | 512,318 | - |
| 576 | CDIO | Cardio Diagnostics Holdings, Inc. | 4.38M | -13.98% | 645,635 | 15.78K |
| 577 | ENVB | Enveric Biosciences, Inc. | 4.18M | -1.69% | 25,528 | - |
| 578 | XRTX | XORTX Therapeutics Inc. | 4.13M | -1.67% | 13,341 | - |
| 579 | ENSC | Ensysce Biosciences, Inc. | 3.85M | -0.93% | 131,584 | 4.49M |
| 580 | CNSP | CNS Pharmaceuticals, Inc. | 3.68M | 7.22% | 20,628 | - |
| 581 | CMND | Clearmind Medicine Inc. | 3.64M | -4.71% | 36,348 | - |
| 582 | OGEN | Oragenics, Inc. | 3.54M | -3.43% | 28,723 | - |
| 583 | PHGE | BiomX Inc. | 3.42M | 3.70% | 31,187 | - |
| 584 | HCWB | HCW Biologics Inc. | 3.30M | -2.40% | 31,411 | 422.03K |
| 585 | AZTR | Azitra, Inc. | 3.26M | -0.03% | 203,314 | 7.50K |
| 586 | ARTL | Artelo Biosciences, Inc. | 3.23M | 3.23% | 546,312 | - |
| 587 | GRI | GRI Bio, Inc. | 2.87M | -4.70% | 9,080,054 | - |
| 588 | BBLG | Bone Biologics Corporation | 2.78M | -1.27% | 44,138 | - |
| 589 | VRAX | Virax Biolabs Group Limited | 2.73M | -9.14% | 744,259 | 2.99K |
| 590 | ONCO | Onconetix, Inc. | 2.67M | -5.49% | 73,112 | 1.22M |
| 591 | SCNI | Scinai Immunotherapeutics Ltd. | 2.57M | 0.66% | 7,672 | 1.15M |
| 592 | DRMA | Dermata Therapeutics, Inc. | 2.52M | -1.83% | 62,861 | - |
| 593 | CDT | CDT Equity Inc. | 2.49M | 3.38% | 35,044 | - |
| 594 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.17M | 3.98% | 296,997 | 1.36M |
| 595 | BDRX | Biodexa Pharmaceuticals Plc | 1.94M | -4.55% | 98,058 | 104.90K |
| 596 | ADTX | Aditxt, Inc. | 1.48M | -0.54% | 183,087 | 5.95K |
| 597 | PBM | Psyence Biomedical Ltd. | 1.44M | -2.77% | 102,198 | - |
| 598 | MLEC | Moolec Science SA | 1.20M | 12.03% | 49,298 | 7.83M |
| 599 | ELAB | PMGC Holdings Inc. | 1.04M | -4.13% | 2,875,823 | 285.95K |